• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

组织蛋白酶E在转甲状腺素蛋白淀粉样变性中的差异表达:从神经病理学到免疫系统

Differential expression of Cathepsin E in transthyretin amyloidosis: from neuropathology to the immune system.

作者信息

Gonçalves Nádia Pereira, Moreira João, Martins Diana, Vieira Paulo, Obici Laura, Merlini Giampaolo, Saraiva Margarida, Saraiva Maria João

机构信息

i3S - Instituto de Investigação e Inovação em Saúde da Universidade do Porto, Rua Alfredo Allen, 208, 4200-135, Porto, Portugal.

Molecular Neurobiology Group, IBMC - Institute for Molecular and Cell Biology, University of Porto, 4150-180, Porto, Portugal.

出版信息

J Neuroinflammation. 2017 Jun 6;14(1):115. doi: 10.1186/s12974-017-0891-9.

DOI:10.1186/s12974-017-0891-9
PMID:28583160
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5460450/
Abstract

BACKGROUND

Increasing evidence supports a key role for inflammation in the neurodegenerative process of familial amyloidotic polyneuropathy (FAP). While there seems to be an overactivation of the neuronal interleukin-1 signaling pathway, the immune response is apparently compromised in FAP. Accordingly, little immune cell infiltration is observed around pre-fibrillar or fibrillar amyloid deposits, with the underlying mechanism for this phenomenon remaining poorly understood. Cathepsin E (CtsE) is an important intermediate for antigen presentation and chemotaxis, but its role in the pathogenesis of FAP disease remains unknown.

METHODS

In this study, we used both mouse primary macrophages and in vivo studies based on transgenic models of FAP and human samples to characterize CtsE expression in different physiological systems.

RESULTS

We show that CtsE is critically decreased in bone marrow-derived macrophages from a FAP mouse model, possibly contributing for cell function impairment. Compromised levels of CtsE were also found in injured nerves of transgenic mice and, most importantly, in naïve peripheral nerves, sensory ganglia, murine stomach, and sural nerve biopsies derived from FAP patients. Expression of CtsE in tissues was associated with transthyretin (TTR) deposition and differentially regulated accordingly with the physiological system under study. Preventing deposition with a TTR small interfering RNA rescued CtsE in the peripheral nervous system (PNS). In contrast, the expression of CtsE increased in splenic cells (mainly monocytes) or peritoneal macrophages, indicating a differential macrophage phenotype.

CONCLUSION

Altogether, our data highlights the potential of CtsE as a novel FAP biomarker and a possible modulator for innate immune cell chemotaxis to the disease most affected tissues-the peripheral nerve and the gastrointestinal tract.

摘要

背景

越来越多的证据支持炎症在家族性淀粉样多神经病(FAP)神经退行性变过程中起关键作用。虽然神经元白细胞介素-1信号通路似乎过度激活,但FAP中的免疫反应显然受损。因此,在原纤维或纤维状淀粉样沉积物周围观察到很少的免疫细胞浸润,这种现象的潜在机制仍知之甚少。组织蛋白酶E(CtsE)是抗原呈递和趋化作用的重要中间体,但其在FAP疾病发病机制中的作用尚不清楚。

方法

在本研究中,我们使用小鼠原代巨噬细胞以及基于FAP转基因模型和人类样本的体内研究来表征不同生理系统中CtsE的表达。

结果

我们发现FAP小鼠模型的骨髓来源巨噬细胞中CtsE显著降低,这可能导致细胞功能受损。在转基因小鼠的损伤神经中也发现CtsE水平受损,最重要的是,在FAP患者的未受损外周神经、感觉神经节、小鼠胃和腓肠神经活检组织中也发现了CtsE水平受损。组织中CtsE的表达与转甲状腺素蛋白(TTR)沉积相关,并根据所研究的生理系统受到不同调节。用TTR小干扰RNA阻止沉积可挽救外周神经系统(PNS)中的CtsE。相反,CtsE在脾细胞(主要是单核细胞)或腹膜巨噬细胞中的表达增加,表明巨噬细胞表型存在差异。

结论

总之,我们的数据突出了CtsE作为一种新型FAP生物标志物的潜力,以及作为先天性免疫细胞向受疾病影响最严重的组织——外周神经和胃肠道趋化的可能调节剂。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/14b2/5460450/34a8f9ad1840/12974_2017_891_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/14b2/5460450/974de85f8b8a/12974_2017_891_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/14b2/5460450/6f9b81a35af3/12974_2017_891_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/14b2/5460450/f9e04ca7a3a2/12974_2017_891_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/14b2/5460450/1bfd3c076d89/12974_2017_891_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/14b2/5460450/34a8f9ad1840/12974_2017_891_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/14b2/5460450/974de85f8b8a/12974_2017_891_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/14b2/5460450/6f9b81a35af3/12974_2017_891_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/14b2/5460450/f9e04ca7a3a2/12974_2017_891_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/14b2/5460450/1bfd3c076d89/12974_2017_891_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/14b2/5460450/34a8f9ad1840/12974_2017_891_Fig5_HTML.jpg

相似文献

1
Differential expression of Cathepsin E in transthyretin amyloidosis: from neuropathology to the immune system.组织蛋白酶E在转甲状腺素蛋白淀粉样变性中的差异表达:从神经病理学到免疫系统
J Neuroinflammation. 2017 Jun 6;14(1):115. doi: 10.1186/s12974-017-0891-9.
2
Schwann cells contribute to neurodegeneration in transthyretin amyloidosis.施万细胞在转甲状腺素蛋白淀粉样变性中促成神经变性。
J Neurochem. 2015 Jul;134(1):66-74. doi: 10.1111/jnc.13068. Epub 2015 Mar 2.
3
MMP-14 overexpression correlates with the neurodegenerative process in familial amyloidotic polyneuropathy.MMP-14 过表达与家族性淀粉样多发性神经病的神经退行性过程相关。
Dis Model Mech. 2017 Oct 1;10(10):1253-1260. doi: 10.1242/dmm.028571.
4
The inflammatory response to sciatic nerve injury in a familial amyloidotic polyneuropathy mouse model.家族性淀粉样多神经病小鼠模型坐骨神经损伤的炎症反应。
Exp Neurol. 2014 Jul;257:76-87. doi: 10.1016/j.expneurol.2014.04.030. Epub 2014 May 5.
5
Sensory nerve degeneration in a mouse model mimicking early manifestations of familial amyloid polyneuropathy due to transthyretin Ala97Ser.转甲状腺素蛋白 Ala97Ser 所致家族性淀粉样多发性神经病早期表现的小鼠模型中的感觉神经退行性变。
Neuropathol Appl Neurobiol. 2018 Dec;44(7):673-686. doi: 10.1111/nan.12477. Epub 2018 Mar 25.
6
Epigallocatechin-3-gallate as a potential therapeutic drug for TTR-related amyloidosis: "in vivo" evidence from FAP mice models.没食子儿茶素-3-没食子酸酯作为一种潜在的转甲状腺素相关淀粉样变性治疗药物的研究:来自家族性淀粉样多发性神经病变小鼠模型的“体内”证据。
PLoS One. 2012;7(1):e29933. doi: 10.1371/journal.pone.0029933. Epub 2012 Jan 10.
7
Clusterin overexpression and its possible protective role in transthyretin deposition in familial amyloidotic polyneuropathy.簇集蛋白过表达及其在家族性淀粉样多发性神经病转甲状腺素蛋白沉积中的可能保护作用。
J Neuropathol Exp Neurol. 2011 Dec;70(12):1097-106. doi: 10.1097/NEN.0b013e31823a44f4.
8
Neurodegeneration in familial amyloid polyneuropathy: from pathology to molecular signaling.家族性淀粉样多神经病中的神经退行性变:从病理学到分子信号传导
Prog Neurobiol. 2003 Dec;71(5):385-400. doi: 10.1016/j.pneurobio.2003.11.002.
9
The Expression of Chemokines Is Downregulated in a Pre-Clinical Model of TTR V30M Amyloidosis.在转甲状腺素蛋白 V30M 淀粉样变性的临床前模型中,趋化因子的表达下调。
Front Immunol. 2021 May 19;12:650269. doi: 10.3389/fimmu.2021.650269. eCollection 2021.
10
Protective role of anakinra against transthyretin-mediated axonal loss and cell death in a mouse model of familial amyloidotic polyneuropathy.在家族性淀粉样多神经病小鼠模型中,阿那白滞素对转甲状腺素蛋白介导的轴突损失和细胞死亡的保护作用。
J Neuropathol Exp Neurol. 2015 Mar;74(3):203-17. doi: 10.1097/NEN.0000000000000164.

引用本文的文献

1
A novel efferocytosis-related gene signature for predicting prognosis and therapeutic response in bladder cancer.一种用于预测膀胱癌预后和治疗反应的新型与胞葬作用相关的基因特征。
Sci Rep. 2025 Jun 6;15(1):19912. doi: 10.1038/s41598-025-04037-w.
2
Regulatory Mechanisms and Therapeutic Implications of Lysosomal Dysfunction in Alzheimer's Disease.阿尔茨海默病中溶酶体功能障碍的调节机制及治疗意义
Int J Biol Sci. 2025 Jan 13;21(3):1014-1031. doi: 10.7150/ijbs.103028. eCollection 2025.
3
Transcriptional analysis of cancer cachexia: conserved and unique features across preclinical models and biological sex.

本文引用的文献

1
Schwann cell and endothelial cell damage in transthyretin familial amyloid polyneuropathy.转甲状腺素蛋白家族性淀粉样多神经病中的施万细胞和内皮细胞损伤
Neurology. 2016 Nov 22;87(21):2220-2229. doi: 10.1212/WNL.0000000000003362. Epub 2016 Oct 28.
2
Involvement of Macrophages in the Pathogenesis of Familial Amyloid Polyneuropathy and Efficacy of Human iPS Cell-Derived Macrophages in Its Treatment.巨噬细胞在家族性淀粉样多神经病发病机制中的作用及人诱导多能干细胞衍生巨噬细胞对其治疗的效果
PLoS One. 2016 Oct 3;11(10):e0163944. doi: 10.1371/journal.pone.0163944. eCollection 2016.
3
Tissue remodeling after interference RNA mediated knockdown of transthyretin in a familial amyloidotic polyneuropathy mouse model.
癌症恶病质的转录组学分析:临床前模型和生物性别之间的保守和独特特征。
Am J Physiol Cell Physiol. 2024 Dec 1;327(6):C1514-C1531. doi: 10.1152/ajpcell.00647.2024. Epub 2024 Oct 28.
4
Broadening Horizons: Exploring the Cathepsin Family as Therapeutic Targets for Alzheimer's Disease.拓展视野:探索组织蛋白酶家族作为阿尔茨海默病的治疗靶点
Aging Dis. 2024 Jul 27. doi: 10.14336/AD.2024.0456.
5
Novel insights into the nervous system affected by prolonged hyperglycemia.对长期高血糖影响神经系统的新认识。
J Mol Med (Berl). 2023 Aug;101(8):1015-1028. doi: 10.1007/s00109-023-02347-y. Epub 2023 Jul 18.
6
FVB/N mouse strain regulatory T cells differ in phenotype and function from the C57BL/6 and BALB/C strains.FVB/N小鼠品系的调节性T细胞在表型和功能上与C57BL/6和BALB/C品系不同。
FASEB Bioadv. 2022 Jun 24;4(10):648-661. doi: 10.1096/fba.2021-00161. eCollection 2022 Oct.
7
Microglial cathepsin E plays a role in neuroinflammation and amyloid β production in Alzheimer's disease.小胶质细胞组织蛋白酶 E 在阿尔茨海默病的神经炎症和淀粉样 β 生成中发挥作用。
Aging Cell. 2022 Mar;21(3):e13565. doi: 10.1111/acel.13565. Epub 2022 Feb 19.
8
In Vitro and In Vivo Effects of SerpinA1 on the Modulation of Transthyretin Proteolysis.丝氨酸蛋白酶抑制剂 A1 对转甲状腺素蛋白蛋白水解的体外和体内调节作用。
Int J Mol Sci. 2021 Aug 31;22(17):9488. doi: 10.3390/ijms22179488.
9
Impaired in vitro growth response of plasma-treated cardiomyocytes predicts poor outcome in patients with transthyretin amyloidosis.经血浆处理的心肌细胞体外生长反应受损可预测转甲状腺素蛋白淀粉样变性患者的不良预后。
Clin Res Cardiol. 2021 Apr;110(4):579-590. doi: 10.1007/s00392-020-01801-y. Epub 2021 Jan 22.
10
Cathepsins in the Pathophysiology of Mucopolysaccharidoses: New Perspectives for Therapy.黏多糖贮积症发病机制中的组织蛋白酶:治疗的新视角。
Cells. 2020 Apr 15;9(4):979. doi: 10.3390/cells9040979.
Neurobiol Aging. 2016 Nov;47:91-101. doi: 10.1016/j.neurobiolaging.2016.07.020. Epub 2016 Aug 1.
4
Transthyretin provides trophic support via megalin by promoting neurite outgrowth and neuroprotection in cerebral ischemia.甲状腺素运载蛋白通过巨蛋白提供营养支持,促进脑缺血时的神经突生长和神经保护。
Cell Death Differ. 2016 Nov 1;23(11):1749-1764. doi: 10.1038/cdd.2016.64. Epub 2016 Aug 12.
5
Impairment of autophagy by TTR V30M aggregates: in vivo reversal by TUDCA and curcumin.转甲状腺素蛋白 V30M 聚集物对自噬的损害:TUDCA 和姜黄素的体内逆转作用。
Clin Sci (Lond). 2016 Sep 1;130(18):1665-75. doi: 10.1042/CS20160075. Epub 2016 Jul 6.
6
Overexpression of Protocadherin-10 in Transthyretin-Related Familial Amyloidotic Polyneuropathy.甲状腺素运载蛋白相关家族性淀粉样多发性神经病中原钙黏蛋白-10的过表达
Am J Pathol. 2016 Jul;186(7):1913-24. doi: 10.1016/j.ajpath.2016.02.020.
7
Curcumin: A multi-target disease-modifying agent for late-stage transthyretin amyloidosis.姜黄素:一种用于晚期转甲状腺素蛋白淀粉样变性的多靶点疾病修饰剂。
Sci Rep. 2016 May 20;6:26623. doi: 10.1038/srep26623.
8
Preclinical evaluation of RNAi as a treatment for transthyretin-mediated amyloidosis.RNA干扰作为转甲状腺素蛋白介导的淀粉样变性治疗方法的临床前评估。
Amyloid. 2016 Jun;23(2):109-18. doi: 10.3109/13506129.2016.1160882. Epub 2016 Mar 31.
9
Contribution of metabolic reprogramming to macrophage plasticity and function.代谢重编程对巨噬细胞可塑性和功能的作用。
Semin Immunol. 2015 Aug;27(4):267-75. doi: 10.1016/j.smim.2015.09.001. Epub 2015 Oct 9.
10
Transthyretin deposition in articular cartilage: a novel mechanism in the pathogenesis of osteoarthritis.关节软骨中转甲状腺素蛋白沉积:骨关节炎发病机制中的新机制。
Arthritis Rheumatol. 2015 May;67(8):2097-107. doi: 10.1002/art.39178.